Mylan Inc.

Mylan Inc. (Mylan) is a pharmaceutical company focused on the development, licensing, production, commercialization and distribution of generic and branded generic pharmaceutical products and active pharmaceutical ingredients (API). The company markets more than 570 products to consumers in more than 140 countries and territories across the world. The company currently operates its business in three reportable segments namely Generics Segment, Specialty Segment and Matrix Segment. The company is headquartered at Canonsburg in Pennsylvania, United States.The company reported revenues of (U.S. Dollars) USD 5,092.79 million during the fiscal year ended December 2009, a decrease of 0.87% from 2008. The operating profit of the company was USD 523.35 million during the fiscal year 2009, an increase of 75.69% over 2008. The net profit of the company was USD 232.57 million during the fiscal year 2009, whereas the company reported a net loss of USD 196.08 million during 2008.

Street: 
1500 Corporate Drive
City: 
Canonsburg
Postcode: 
15317
Federal State : 
United States
WebSite: 
http://www.mylan.com
Fax: 
1-724-5141870

Company Index Score

Current Index Score Historical Index Score
  • Mylan Inc. currently scores 50 % in the index.
  • Mylan Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Mylan Inc. is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets